BioVersys has entered an exclusive collaboration and license agreement with Hackensack Meridian Health (HMH) to enhance its Ansamycin Chemistry platform targeting difficult-to-treat non-tuberculous mycobacteria (NTM) diseases. This partnership combines BioVersys’ proprietary drug candidates with novel molecules developed by HMH’s Center for Discovery and Innovation, aiming to develop potent oral treatments for NTM infections, which primarily affect patients with chronic lung conditions like cystic fibrosis and COPD. The collaboration supports BioVersys’ ongoing BV500 program and reflects a commitment to addressing the high unmet medical need for effective NTM therapies. HMH will receive upfront payments and royalties from future sales, while both parties work towards advancing clinical candidates.
A regional nonprofit health plan reduced its Transparency in Coverage machine-readable file (MRF) production time from 45 days to less than 24 hours by integrating TALON's platform directly with its claims administration system. This eliminated a com...
ASUS has introduced two new Chromebooks in the US market: the budget-friendly CM15 laptop and the versatile CM32 Detachable 2-in-1 device. Both run on the MediaTek Kompanio 540 processor, offer up to 12 hours of battery life, and feature military-gra...
Slate Medicines, a biotech firm focused on migraine treatments, has appointed Mark W. Hahn to its Board of Directors. Hahn brings over 25 years of experience in life sciences, including leading companies through financial milestones and FDA approvals...
The global clinical trials market is projected to grow from $135.51 billion in 2026 to $176.32 billion by 2030, at a CAGR of 6.8%. Growth is fueled by advances in AI-enabled trial design, decentralized and hybrid trial platforms, and increasing deman...
The global hybrid robots market is projected to grow from $5.68 billion in 2026 to $10.03 billion by 2030, with a CAGR of 15.3%. Growth is fueled by advances in AI, autonomous operations, and smart manufacturing, alongside rising demand for robots in...
